In 2002, the British Association of Dermatologists produced the first guidelines for the management of lichen sclerosus (LS). These guidelines have been updated twice since then, once in 2010 and again recently in 2018 (published in this issue of the BJD).1 They aim to offer evidence-based recommendations for diagnosis and management of LS in both adult and paediatric patients.
The authors offer a comprehensive study of genital LS in particular, a disease with an estimated prevalence in adult females of up to 3%2 and 0.07% in males.